Following another rare earth development play I have been in and out of, sold a while ago when it was .25 as market cap was over 500 million, just released it's scoping study, very good cost per ore , but all other aspects make the project marginal at current price, requires funding over 400 million USD for development, to ramp up 5mtp to produce 11kt per annually, so higher extraction then peaks , also different extraction as an ionic clay. The main issue is dry stacking as tailing filter press are very finicky to get right , I own a copper play that's finding that out the hard way and ordering a second press to get to its designed output. Anyhow this company scoping study certainly reinforces my position on peak for several reasons. Multi commodity, experienced partnership (MP as example) and lower capex with potential buy in partnership. 50 million mkt cap seems pretty cheap compared the the company that released the scoping study current mkt cap at 300 million.
- Forums
- ASX - By Stock
- PEK
- Interesting read stockpiling
PEK
peak rare earths limited
Add to My Watchlist
1.75%
!
28.0¢

Interesting read stockpiling, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $98.59M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 28.0¢ | $105.9K | 373.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 678908 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 1400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 678908 | 0.280 |
8 | 357000 | 0.275 |
6 | 426678 | 0.270 |
6 | 369000 | 0.265 |
7 | 1526383 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 1400 | 1 |
0.290 | 63366 | 4 |
0.300 | 153029 | 3 |
0.310 | 6600 | 2 |
0.320 | 182112 | 3 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online